CHARLESTON, W.Va. (AP) — The U.S. Drug Enforcement Administration has approved a rule change requiring drugmakers to identify a legitimate need for opioids to justify their production in an attempt to rein in their diversion for illicit purposes.
The DEA announced recently that the final rule sent for publication in the Federal Register will consider the extent to which a legally prescribed drug is diverted for abuse when the agency sets its annual opioid production limits.
The rule requires DEA to share notices of proposed aggregate production quotas and final aggregate production quota orders with state attorneys general.
Attorney General Jeff Sessions says the new rule “will allow the DEA to be more responsive to the facts on the ground.”
- Posted July 16, 2018
- Tweet This | Share on Facebook
Rule changes so drugmakers must justify need for opioids
headlines Macomb
- Nonprofit gets a boost
- Nessel joins multistate coalition to defend U.S. EPA’s greenhouse gas emissions standards for heavy-duty vehicles
- Michigan 529 Awareness Day calls on families to save with MET and MESP for children’s educational future
- Department highlights importance of 988 Suicide and Crisis Lifeline during Mental Health Month
- No charges for officer in death of Michigan teen struck by police car during chase
headlines National
- This Los Angeles lawyer found her calling as a death doula
- ACLU and BigLaw firm use ‘Orange is the New Black’ in hashtag effort to promote NY jail reform
- Artificial intelligence tools for brief writing and analysis are a small firm litigator’s new best friend
- Baker McKenzie partner drops suit seeking IRS documents on partnership scrutiny
- Family members sue networks after learning of loved ones’ deaths by seeing bodies on TV
- Ex-BigLaw attorney once ‘consumed with remorse’ over $10M client theft sentenced in new scheme